BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oyrer J, Maljevic S, Scheffer IE, Berkovic SF, Petrou S, Reid CA. Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies. Pharmacol Rev 2018;70:142-73. [PMID: 29263209 DOI: 10.1124/pr.117.014456] [Cited by in Crossref: 92] [Cited by in F6Publishing: 73] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Difrancesco JC, Castellotti B, Milanesi R, Ragona F, Freri E, Canafoglia L, Franceschetti S, Ferrarese C, Magri S, Taroni F, Costa C, Labate A, Gambardella A, Solazzi R, Binda A, Rivolta I, Di Gennaro G, Casciato S, D’incerti L, Barbuti A, Difrancesco D, Granata T, Gellera C. HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature. Epilepsy Research 2019;153:49-58. [DOI: 10.1016/j.eplepsyres.2019.04.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
2 Soteros BM, Sia GM. Complement and microglia dependent synapse elimination in brain development. WIREs Mech Dis 2021;:e1545. [PMID: 34738335 DOI: 10.1002/wsbm.1545] [Reference Citation Analysis]
3 Shen D, Chen J, Liu D, Shen M, Wang X, Wu Y, Ke S, Macdonald RL, Zhang Q. The GABRG2 F343L allele causes spontaneous seizures in a novel transgenic zebrafish model that can be treated with suberanilohydroxamic acid (SAHA). Ann Transl Med 2020;8:1560. [PMID: 33437759 DOI: 10.21037/atm-20-3745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi L, Zhu M, Li H, Wen Z, Chen X, Luo J, Lin C, Zhang Z. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Eur J Clin Pharmacol 2019;75:655-63. [PMID: 30693367 DOI: 10.1007/s00228-019-02633-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Reid CA, Rollo B, Petrou S, Berkovic SF. Can mutation‐mediated effects occurring early in development cause long‐term seizure susceptibility in genetic generalized epilepsies? Epilepsia 2018;59:915-22. [DOI: 10.1111/epi.14077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hedrich UBS, Lauxmann S, Lerche H. SCN2A channelopathies: Mechanisms and models. Epilepsia 2019;60 Suppl 3:S68-76. [PMID: 31904120 DOI: 10.1111/epi.14731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Cao Q, Yang F, Wang H. CB2R induces a protective response against epileptic seizures through ERK and p38 signaling pathways. International Journal of Neuroscience 2021;131:735-44. [DOI: 10.1080/00207454.2020.1796661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 [DOI: 10.1101/671453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Spoto G, Saia MC, Amore G, Gitto E, Loddo G, Mainieri G, Nicotera AG, Di Rosa G. Neonatal Seizures: An Overview of Genetic Causes and Treatment Options. Brain Sci 2021;11:1295. [PMID: 34679360 DOI: 10.3390/brainsci11101295] [Reference Citation Analysis]
10 Carpenter JC, Lignani G. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies? Neurotherapeutics 2021. [PMID: 34235638 DOI: 10.1007/s13311-021-01081-y] [Reference Citation Analysis]
11 Kalser J, Cross JH. New epilepsy treatment in children: upcoming strategies and rewind to ancient times and concepts. Paediatrics and Child Health 2018;28:474-9. [DOI: 10.1016/j.paed.2018.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Gertler TS, Thompson CH, Vanoye CG, Millichap JJ, George AL Jr. Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy. Ann Clin Transl Neurol 2019;6:1606-15. [PMID: 31560846 DOI: 10.1002/acn3.50847] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 Allen NM, Weckhuysen S, Gorman K, King MD, Lerche H. Genetic potassium channel-associated epilepsies: Clinical review of the Kv family. Eur J Paediatr Neurol 2020;24:105-16. [PMID: 31932120 DOI: 10.1016/j.ejpn.2019.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
14 Weng OY, Li Y, Wang L. Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway. Front Mol Neurosci 2022;15:810081. [DOI: 10.3389/fnmol.2022.810081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Teng X, Aouacheria A, Lionnard L, Metz KA, Soane L, Kamiya A, Hardwick JM. KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neurosci Ther 2019;25:887-902. [PMID: 31197948 DOI: 10.1111/cns.13156] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
16 Yamagata A, Fukai S. Insights into the mechanisms of epilepsy from structural biology of LGI1–ADAM22. Cell Mol Life Sci 2020;77:267-74. [DOI: 10.1007/s00018-019-03269-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Focken T, Burford K, Grimwood ME, Zenova A, Andrez JC, Gong W, Wilson M, Taron M, Decker S, Lofstrand V, Chowdhury S, Shuart N, Lin S, Goodchild SJ, Young C, Soriano M, Tari PK, Waldbrook M, Nelkenbrecher K, Kwan R, Lindgren A, de Boer G, Lee S, Sojo L, DeVita RJ, Cohen CJ, Wesolowski SS, Johnson JP Jr, Dehnhardt CM, Empfield JR. Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy. J Med Chem 2019;62:9618-41. [PMID: 31525968 DOI: 10.1021/acs.jmedchem.9b01032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 Martin-Batista E, Manville RW, Rivero-Pérez B, Bartolomé-Martín D, Alvarez de la Rosa D, Abbott GW, Giraldez T. Activation of SGK1.1 Upregulates the M-current in the Presence of Epilepsy Mutations. Front Mol Neurosci 2021;14:798261. [PMID: 34899186 DOI: 10.3389/fnmol.2021.798261] [Reference Citation Analysis]
19 Larson EA, Accardi MV, Zhong Y, Paquette D, Authier S. Drug-Induced Seizures: Considerations for Underlying Molecular Mechanisms. Int J Toxicol 2021;40:403-12. [PMID: 34514888 DOI: 10.1177/10915818211040483] [Reference Citation Analysis]
20 Kahlig KM, Scott L, Hatch RJ, Griffin A, Martinez Botella G, Hughes ZA, Wittmann M. The novel persistent sodium current inhibitor PRAX-562 has potent anticonvulsant activity with improved protective index relative to standard of care sodium channel blockers. Epilepsia 2022. [PMID: 35037706 DOI: 10.1111/epi.17149] [Reference Citation Analysis]
21 Heyne HO, Baez-nieto D, Iqbal S, Palmer DS, Brunklaus A, May P, Johannesen KM, Lauxmann S, Lemke JR, Møller RS, Pérez-palma E, Scholl UI, Syrbe S, Lerche H, Lal D, Campbell AJ, Wang H, Pan J, Daly MJ; Epi25 Collaborative. Predicting functional effects of missense variants in voltage-gated sodium and calcium channels. Sci Transl Med 2020;12:eaay6848. [DOI: 10.1126/scitranslmed.aay6848] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
22 Helbig I, Riggs ER, Barry CA, Klein KM, Dyment D, Thaxton C, Sadikovic B, Sands TT, Wagnon JL, Liaquat K, Cilio MR, Mirzaa G, Park K, Axeen E, Butler E, Bardakjian TM, Striano P, Poduri A, Siegert RK, Grant AR, Helbig KL, Mefford HC. The ClinGen Epilepsy Gene Curation Expert Panel-Bridging the divide between clinical domain knowledge and formal gene curation criteria. Hum Mutat 2018;39:1476-84. [PMID: 30311377 DOI: 10.1002/humu.23632] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
23 Ellis CA, Petrovski S, Berkovic SF. Epilepsy genetics: clinical impacts and biological insights. Lancet Neurol 2020;19:93-100. [PMID: 31494011 DOI: 10.1016/S1474-4422(19)30269-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 9.7] [Reference Citation Analysis]
24 Bleakley LE, McKenzie CE, Soh MS, Forster IC, Pinares-Garcia P, Sedo A, Kathirvel A, Churilov L, Jancovski N, Maljevic S, Berkovic SF, Scheffer IE, Petrou S, Santoro B, Reid CA. Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy. Brain 2021;144:2060-73. [PMID: 33822003 DOI: 10.1093/brain/awab145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Beijer D, Baets J. The expanding genetic landscape of hereditary motor neuropathies. Brain 2020;143:3540-63. [PMID: 33210134 DOI: 10.1093/brain/awaa311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cook AA, Fields E, Watt AJ. Losing the Beat: Contribution of Purkinje Cell Firing Dysfunction to Disease, and Its Reversal. Neuroscience 2021;462:247-61. [PMID: 32554108 DOI: 10.1016/j.neuroscience.2020.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
27 Simonato M, Agoston DV, Brooks-Kayal A, Dulla C, Fureman B, Henshall DC, Pitkänen A, Theodore WH, Twyman RE, Kobeissy FH, Wang KK, Whittemore V, Wilcox KS. Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap. Nat Rev Neurol 2021;17:231-42. [PMID: 33594276 DOI: 10.1038/s41582-021-00461-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
28 Roberts R, Authier S, Mellon RD, Morton M, Suzuki I, Tjalkens RB, Valentin JP, Pierson JB. Can We Panelize Seizure? Toxicol Sci 2021;179:3-13. [PMID: 33165543 DOI: 10.1093/toxsci/kfaa167] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Markus F, Angelini C, Trimouille A, Rudolf G, Lesca G, Goizet C, Lasseaux E, Arveiler B, van Slegtenhorst M, Brooks AS, Abou Jamra R, Korenke GC, Neidhardt J, Owczarek-Lipska M. Rare variants in the GABAA receptor subunit ε identified in patients with a wide spectrum of epileptic phenotypes. Mol Genet Genomic Med 2020;8:e1388. [PMID: 32588540 DOI: 10.1002/mgg3.1388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Liu J, Tong L, Song S, Niu Y, Li J, Wu X, Zhang J, Zai CC, Luo F, Wu J, Li H, Wong AHC, Sun R, Liu F, Li B. Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain 2018;11:48. [PMID: 30185235 DOI: 10.1186/s13041-018-0392-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
31 Jahanbani R, Bahramnejad E, Rahimi N, Shafaroodi H, Sheibani N, Moosavi-Movahedi AA, Dehpour AR, Vahdati K. Anti-seizure effects of walnut peptides in mouse models of induced seizure: The involvement of GABA and nitric oxide pathways. Epilepsy Res 2021;176:106727. [PMID: 34333374 DOI: 10.1016/j.eplepsyres.2021.106727] [Reference Citation Analysis]
32 Chen TS, Lai MC, Huang HI, Wu SN, Huang CW. Immunity, Ion Channels and Epilepsy. Int J Mol Sci 2022;23:6446. [PMID: 35742889 DOI: 10.3390/ijms23126446] [Reference Citation Analysis]
33 Smith RS, Walsh CA. Ion Channel Functions in Early Brain Development. Trends Neurosci 2020;43:103-14. [PMID: 31959360 DOI: 10.1016/j.tins.2019.12.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
34 Siucinska E. Γ-Aminobutyric acid in adult brain: an update. Behavioural Brain Research 2019;376:112224. [DOI: 10.1016/j.bbr.2019.112224] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
35 Milligan CJ, Pachernegg S. Utilising Automated Electrophysiological Platforms in Epilepsy Research. Methods Mol Biol 2021;2188:133-55. [PMID: 33119850 DOI: 10.1007/978-1-0716-0818-0_7] [Reference Citation Analysis]
36 Van Loo KMJ, Carvill GL, Becker AJ, Conboy K, Goldman AM, Kobow K, Lopes-Cendes I, Reid CA, van Vliet EA, Henshall DC. Epigenetic genes and epilepsy - emerging mechanisms and clinical applications. Nat Rev Neurol 2022. [PMID: 35859062 DOI: 10.1038/s41582-022-00693-y] [Reference Citation Analysis]
37 Trivisano M, Ferretti A, Bebin E, Huh L, Lesca G, Siekierska A, Takeguchi R, Carneiro M, De Palma L, Guella I, Haginoya K, Shi RM, Kikuchi A, Kobayashi T, Jung J, Lagae L, Milh M, Mathieu ML, Minassian BA, Novelli A, Pietrafusa N, Takeshita E, Tartaglia M, Terracciano A, Thompson ML, Cooper GM, Vigevano F, Villard L, Villeneuve N, Buyse GM, Demos M, Scheffer IE, Specchio N. Defining the phenotype of FHF1 developmental and epileptic encephalopathy. Epilepsia 2020;61:e71-8. [PMID: 32645220 DOI: 10.1111/epi.16582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Li M, Jancovski N, Jafar-Nejad P, Burbano LE, Rollo B, Richards K, Drew L, Sedo A, Heighway J, Pachernegg S, Soriano A, Jia L, Blackburn T, Roberts B, Nemiroff A, Dalby K, Maljevic S, Reid CA, Rigo F, Petrou S. Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model. J Clin Invest 2021;131:e152079. [PMID: 34850743 DOI: 10.1172/JCI152079] [Reference Citation Analysis]
39 Yu Z, Zhang M, Luo B, Jing H, Yu Y, Wang S, Luo S. Lrp4 in hippocampal astrocytes serves as a negative feedback factor in seizures. Cell Biosci 2020;10:135. [PMID: 33292473 DOI: 10.1186/s13578-020-00498-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Akyuz E, Paudel YN, Polat AK, Dundar HE, Angelopoulou E. Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities. Epilepsy Behav 2021;115:107701. [PMID: 33412369 DOI: 10.1016/j.yebeh.2020.107701] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
41 Emmenegger V, Obien MEJ, Franke F, Hierlemann A. Technologies to Study Action Potential Propagation With a Focus on HD-MEAs. Front Cell Neurosci 2019;13:159. [PMID: 31118887 DOI: 10.3389/fncel.2019.00159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Li L, Zhang C, Wang Z, Guo Y, Wang Y, Fan X, Jiang T. Expression changes in ion channel and immunity genes are associated with glioma-related epilepsy in patients with diffuse gliomas. J Cancer Res Clin Oncol 2022. [PMID: 35581384 DOI: 10.1007/s00432-022-04049-3] [Reference Citation Analysis]
43 Magalhães PHM, Moraes HT, Athie MCP, Secolin R, Lopes-Cendes I. New avenues in molecular genetics for the diagnosis and application of therapeutics to the epilepsies. Epilepsy Behav 2021;121:106428. [PMID: 31400936 DOI: 10.1016/j.yebeh.2019.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Miao P, Tang S, Ye J, Wang J, Lou Y, Zhang B, Xu X, Chen X, Li Y, Feng J. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy. Mol Genet Genomic Med 2020;8:e1250. [PMID: 32400968 DOI: 10.1002/mgg3.1250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Thakran S, Guin D, Singh P, Singh P, Kukal S, Rawat C, Yadav S, Kushwaha SS, Srivastava AK, Hasija Y, Saso L, Ramachandran S, Kukreti R. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment. Int J Mol Sci 2020;21:E7784. [PMID: 33096746 DOI: 10.3390/ijms21207784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Godoy LD, Prizon T, Rossignoli MT, Leite JP, Liberato JL. Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention. Front Integr Neurosci 2022;16:765324. [DOI: 10.3389/fnint.2022.765324] [Reference Citation Analysis]
47 Lerche H. Synaptic or ion channel modifier? PRRT2 is a chameleon-like regulator of neuronal excitability. Brain 2018;141:938-41. [PMID: 29596668 DOI: 10.1093/brain/awy073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Kim HJ, Jang HN, Ahn H, Yum MS, Ko TS. Over 10-Year Outcomes of Infantile-Onset Epilepsies. J Clin Med 2021;10:430. [PMID: 33499362 DOI: 10.3390/jcm10030430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Stefani S, Kousiappa I, Nicolaou N, Papathanasiou ES, Oulas A, Fanis P, Neocleous V, Phylactou LA, Spyrou GM, Papacostas SS. Neurophysiological and Genetic Findings in Patients With Juvenile Myoclonic Epilepsy. Front Integr Neurosci 2020;14:45. [PMID: 32973469 DOI: 10.3389/fnint.2020.00045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Gotra P, Bhardwaj N, Ludhiadch A, Singh G, Munshi A. Epilepsy and Migraine Shared Genetic and Molecular Mechanisms: Focus on Therapeutic Strategies. Mol Neurobiol 2021;58:3874-83. [PMID: 33856647 DOI: 10.1007/s12035-021-02386-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Hori K, Tsujikawa S, Novakovic MM, Yamashita M, Prakriya M. Regulation of chemoconvulsant-induced seizures by store-operated Orai1 channels. J Physiol 2020;598:5391-409. [PMID: 32851638 DOI: 10.1113/JP280119] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Sheidley BR, Smith LA, Helbig KL. Genetics of Epilepsy in the Era of Precision Medicine: Implications for Testing, Treatment, and Genetic Counseling. Curr Genet Med Rep 2018;6:73-82. [DOI: 10.1007/s40142-018-0139-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Specchio N, Di Micco V, Trivisano M, Ferretti A, Curatolo P. The epilepsy-autism spectrum disorder phenotype in the era of molecular genetics and precision therapy. Epilepsia 2021. [PMID: 34741464 DOI: 10.1111/epi.17115] [Reference Citation Analysis]
54 Cohen SR, Helbig I, Kaufman MC, Schust Myers L, Conway L, Helbig KL. Caregiver assessment of quality of life in individuals with genetic developmental and epileptic encephalopathies. Dev Med Child Neurol 2022. [PMID: 35229292 DOI: 10.1111/dmcn.15187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Singh AK, Dvorak NM, Tapia CM, Mosebarger A, Ali SR, Bullock Z, Chen H, Zhou J, Laezza F. Differential Modulation of the Voltage-Gated Na+ Channel 1.6 by Peptides Derived From Fibroblast Growth Factor 14. Front Mol Biosci 2021;8:742903. [PMID: 34557523 DOI: 10.3389/fmolb.2021.742903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ritter DM, Horn PS, Holland KD. In Silico Predictions of KCNQ Variant Pathogenicity in Epilepsy. Pediatr Neurol 2021;118:48-54. [PMID: 33784504 DOI: 10.1016/j.pediatrneurol.2021.01.006] [Reference Citation Analysis]
57 Crawley JN, Fagiolini M, Harrison FE, Samaco R, Wozniak DF, Robinson MB. Behavioral analyses of animal models of intellectual and developmental disabilities. Neurobiol Learn Mem 2019;165:107087. [PMID: 31499164 DOI: 10.1016/j.nlm.2019.107087] [Reference Citation Analysis]
58 Crotti L, Odening KE, Sanguinetti MC. Heritable arrhythmias associated with abnormal function of cardiac potassium channels. Cardiovasc Res 2020;116:1542-56. [PMID: 32227190 DOI: 10.1093/cvr/cvaa068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
59 Praticò AD, Falsaperla R, Polizzi A, Ruggieri M. Monogenic Epilepsies: Channelopathies, Synaptopathies, mTorpathies, and Otheropathies. Journal of Pediatric Neurology. [DOI: 10.1055/s-0041-1727098] [Reference Citation Analysis]
60 Yang Y, Niu X, Cheng M, Zeng Q, Deng J, Tian X, Wang Y, Yu J, Shi W, Wu W, Ma J, Li Y, Yang X, Zhang X, Jia T, Yang Z, Liao J, Sun Y, Zheng H, Sun S, Sun D, Jiang Y, Zhang Y. Phenotypic Spectrum and Prognosis of Epilepsy Patients With GABRG2 Variants. Front Mol Neurosci 2022;15:809163. [DOI: 10.3389/fnmol.2022.809163] [Reference Citation Analysis]
61 Fedorenko OA, Khovanov IA, Roberts SK, Guardiani C. Changes in Ion Selectivity Following the Asymmetrical Addition of Charge to the Selectivity Filter of Bacterial Sodium Channels. Entropy (Basel) 2020;22:E1390. [PMID: 33316962 DOI: 10.3390/e22121390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Wang Y, Chen Z. An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy. Pharmacol Ther 2019;201:77-93. [PMID: 31128154 DOI: 10.1016/j.pharmthera.2019.05.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
63 Wang M, Cotter E, Wang YJ, Fu X, Whittsette AL, Lynch JW, Wiseman RL, Kelly JW, Keramidas A, Mu TW. Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors. Cell Biosci 2022;12:48. [PMID: 35477478 DOI: 10.1186/s13578-022-00783-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Bai Y, Zeng C, Jia M, Xiao B. Molecular mechanisms of topiramate and its clinical value in epilepsy. Seizure 2022. [DOI: 10.1016/j.seizure.2022.03.024] [Reference Citation Analysis]
65 Bonzanni M, DiFrancesco JC, Milanesi R, Campostrini G, Castellotti B, Bucchi A, Baruscotti M, Ferrarese C, Franceschetti S, Canafoglia L, Ragona F, Freri E, Labate A, Gambardella A, Costa C, Rivolta I, Gellera C, Granata T, Barbuti A, DiFrancesco D. A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability. Neurobiol Dis 2018;118:55-63. [PMID: 29936235 DOI: 10.1016/j.nbd.2018.06.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
66 Qaiser F, Yuen RKC, Andrade DM. Genetics of Epileptic Networks: from Focal to Generalized Genetic Epilepsies. Curr Neurol Neurosci Rep 2020;20:46. [PMID: 32789700 DOI: 10.1007/s11910-020-01059-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 D'Adamo MC, Liantonio A, Conte E, Pessia M, Imbrici P. Ion Channels Involvement in Neurodevelopmental Disorders. Neuroscience 2020;440:337-59. [PMID: 32473276 DOI: 10.1016/j.neuroscience.2020.05.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
68 Földi MC, Pesti K, Zboray K, Toth AV, Hegedűs T, Málnási-Csizmadia A, Lukacs P, Mike A. The mechanism of non-blocking inhibition of sodium channels revealed by conformation-selective photolabeling. Br J Pharmacol 2021;178:1200-17. [PMID: 33450052 DOI: 10.1111/bph.15365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Hannan S, Minere M, Harris J, Izquierdo P, Thomas P, Tench B, Smart TG. GABAAR isoform and subunit structural motifs determine synaptic and extrasynaptic receptor localisation. Neuropharmacology 2020;169:107540. [PMID: 30794836 DOI: 10.1016/j.neuropharm.2019.02.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
70 International League Against Epilepsy Consortium on Complex Epilepsies. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun 2018;9:5269. [PMID: 30531953 DOI: 10.1038/s41467-018-07524-z] [Cited by in Crossref: 136] [Cited by in F6Publishing: 90] [Article Influence: 34.0] [Reference Citation Analysis]
71 Shah MM. A new HCN1 channelopathy: implications for epilepsy. Brain 2021:awab220. [PMID: 34117499 DOI: 10.1093/brain/awab220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Juliá‐palacios N, Molina‐anguita C, Sigatulina Bondarenko M, Cortès‐saladelafont E, Aparicio J, Cuadras D, Horvath G, Fons C, Artuch R, García‐cazorla À, Ulate‐campos A, Darling A, O’callaghan M, Pías‐peleteiro L, Ormazabal A, Mussarra CO, Valera C, Ramírez‐camacho A; Institut de Recerca Sant Joan de Déu Working Group. Monoamine neurotransmitters in early epileptic encephalopathies: New insights into pathophysiology and therapy. Develop Med Child Neuro. [DOI: 10.1111/dmcn.15140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Epi25 Collaborative. Electronic address: s.berkovic@unimelb.edu.au., Epi25 Collaborative. Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals. Am J Hum Genet 2019;105:267-82. [PMID: 31327507 DOI: 10.1016/j.ajhg.2019.05.020] [Cited by in Crossref: 124] [Cited by in F6Publishing: 78] [Article Influence: 41.3] [Reference Citation Analysis]
74 [DOI: 10.1101/2020.09.09.289900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Vardar G, Gerth F, Schmitt XJ, Rautenstrauch P, Trimbuch T, Schubert J, Lerche H, Rosenmund C, Freund C. Epilepsy-causing STX1B mutations translate altered protein functions into distinct phenotypes in mouse neurons. Brain 2020;143:2119-38. [DOI: 10.1093/brain/awaa151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
76 Becchetti A, Grandi LC, Colombo G, Meneghini S, Amadeo A. Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology. Brain Sci 2020;10:E907. [PMID: 33255633 DOI: 10.3390/brainsci10120907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 van Loo KMJ, Becker AJ. Transcriptional Regulation of Channelopathies in Genetic and Acquired Epilepsies. Front Cell Neurosci 2019;13:587. [PMID: 31992970 DOI: 10.3389/fncel.2019.00587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Qiuju H, Jianlong Z, Qi W, Zhifa L, Ding W, Xiaofang S, Yingjun X. Epilepsy Combined With Multiple Gene Heterozygous Mutation. Front Pediatr 2022;10:763642. [DOI: 10.3389/fped.2022.763642] [Reference Citation Analysis]
79 Qaiser F, Sadoway T, Yin Y, Zulfiqar Ali Q, Nguyen CM, Shum N, Backstrom I, Marques PT, Tabarestani S, Munhoz RP, Krings T, Pearson CE, Yuen RKC, Andrade DM. Genome sequencing identifies rare tandem repeat expansions and copy number variants in Lennox-Gastaut syndrome. Brain Commun 2021;3:fcab207. [PMID: 34622207 DOI: 10.1093/braincomms/fcab207] [Reference Citation Analysis]
80 Maljevic S, Møller RS, Reid CA, Pérez-palma E, Lal D, May P, Lerche H. Spectrum of GABAA receptor variants in epilepsy. Current Opinion in Neurology 2019;32:183-90. [DOI: 10.1097/wco.0000000000000657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
81 Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M, D'Adamo MC, De Luca A, Brankovic V, Zanni G. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. Int J Mol Sci 2021;22:9913. [PMID: 34576077 DOI: 10.3390/ijms22189913] [Reference Citation Analysis]
82 Sun D, Liu Y, Cai W, Ma J, Ni K, Chen M, Wang C, Liu Y, Zhu Y, Liu Z, Zhu F. Detection of Disease-Causing SNVs/Indels and CNVs in Single Test Based on Whole Exome Sequencing: A Retrospective Case Study in Epileptic Encephalopathies. Front Pediatr 2021;9:635703. [PMID: 34055682 DOI: 10.3389/fped.2021.635703] [Reference Citation Analysis]
83 Soh H, Park S, Ryan K, Springer K, Maheshwari A, Tzingounis AV. Deletion of KCNQ2/3 potassium channels from PV+ interneurons leads to homeostatic potentiation of excitatory transmission. Elife 2018;7:e38617. [PMID: 30382937 DOI: 10.7554/eLife.38617] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
84 Akyuz E, Kullu I, Arulsamy A, Shaikh MF. Melatonin as an Antiepileptic Molecule: Therapeutic Implications via Neuroprotective and Inflammatory Mechanisms. ACS Chem Neurosci 2021;12:1281-92. [PMID: 33813829 DOI: 10.1021/acschemneuro.1c00083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Su Z, Li Y, Chen S, Liu X, Zhao K, Peng Y, Zhou L. Identification of Ion Channel-Related Genes and miRNA-mRNA Networks in Mesial Temporal Lobe Epilepsy. Front Genet 2022;13:853529. [PMID: 35422840 DOI: 10.3389/fgene.2022.853529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Xie ZQ, Tian XT, Zheng YM, Zhan L, Chen XQ, Xin XM, Huang CG, Gao ZB. Antiepileptic geissoschizine methyl ether is an inhibitor of multiple neuronal channels. Acta Pharmacol Sin 2020;41:629-37. [PMID: 31911638 DOI: 10.1038/s41401-019-0327-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Liu YD, Ma MY, Hu XB, Yan H, Zhang YK, Yang HX, Feng JH, Wang L, Zhang H, Zhang B, Li QB, Zhang JC, Kong QX. Brain Proteomic Profiling in Intractable Epilepsy Caused by TSC1 Truncating Mutations: A Small Sample Study. Front Neurol 2020;11:475. [PMID: 32655475 DOI: 10.3389/fneur.2020.00475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Xie C, Liu F, He H, He F, Mao L, Wang X, Yin F, Peng J. Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability. Front Mol Neurosci 2022;15:870182. [DOI: 10.3389/fnmol.2022.870182] [Reference Citation Analysis]
89 Borja GB, Zhang H, Harwood BN, Jacques J, Grooms J, Chantre RO, Zhang D, Barnett A, Werley CA, Lu Y, Nagle SF, Mcmanus OB, Dempsey GT. Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells. Front Mol Neurosci 2022;15:896320. [DOI: 10.3389/fnmol.2022.896320] [Reference Citation Analysis]
90 Ritter DM, Holland K. Genetic Testing in Epilepsy. Semin Neurol 2020;40:730-8. [PMID: 33176374 DOI: 10.1055/s-0040-1719070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Metz KA, Teng X, Coppens I, Lamb HM, Wagner BE, Rosenfeld JA, Chen X, Zhang Y, Kim HJ, Meadow ME, Wang TS, Haberlandt ED, Anderson GW, Leshinsky-Silver E, Bi W, Markello TC, Pratt M, Makhseed N, Garnica A, Danylchuk NR, Burrow TA, Jayakar P, McKnight D, Agadi S, Gbedawo H, Stanley C, Alber M, Prehl I, Peariso K, Ong MT, Mordekar SR, Parker MJ, Crooks D, Agrawal PB, Berry GT, Loddenkemper T, Yang Y, Maegawa GHB, Aouacheria A, Markle JG, Wohlschlegel JA, Hartman AL, Hardwick JM. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect. Ann Neurol 2018;84:766-80. [PMID: 30295347 DOI: 10.1002/ana.25351] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
92 Duan R, Li HM, Hu WB, Hong CG, Chen ML, Cao J, Wang ZX, Chen CY, Yin F, Hu ZH, Li JD, Xie H, Liu ZZ. Recurrent de novo single point variant on the gene encoding Na+/K+ pump results in epilepsy. Prog Neurobiol 2022;216:102310. [PMID: 35724808 DOI: 10.1016/j.pneurobio.2022.102310] [Reference Citation Analysis]
93 Shore AN, Colombo S, Tobin WF, Petri S, Cullen ER, Dominguez S, Bostick CD, Beaumont MA, Williams D, Khodagholy D, Yang M, Lutz CM, Peng Y, Gelinas JN, Goldstein DB, Boland MJ, Frankel WN, Weston MC. Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy. Cell Rep 2020;33:108303. [PMID: 33113364 DOI: 10.1016/j.celrep.2020.108303] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
94 Joshi P, Patel R, Kang SY, Serbinowski E, Lee MY. Establishment of ion channel and ABC transporter assays in 3D-cultured ReNcell VM on a 384-pillar plate for neurotoxicity potential. Toxicol In Vitro 2022;:105375. [PMID: 35550413 DOI: 10.1016/j.tiv.2022.105375] [Reference Citation Analysis]
95 Lauxmann S, Verbeek NE, Liu Y, Zaichuk M, Müller S, Lemke JR, van Kempen MJ, Lerche H, Hedrich UB. Relationship of electrophysiological dysfunction and clinical severity in SCN2A -related epilepsies. Human Mutation 2018;39:1942-56. [DOI: 10.1002/humu.23619] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
96 Gan J, Cai Q, Galer P, Ma D, Chen X, Huang J, Bao S, Luo R. Mapping the knowledge structure and trends of epilepsy genetics over the past decade: A co-word analysis based on medical subject headings terms. Medicine (Baltimore) 2019;98:e16782. [PMID: 31393404 DOI: 10.1097/MD.0000000000016782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
97 Koko M, Krause R, Sander T, Bobbili DR, Nothnagel M, May P, Lerche H; Epi25 Collaborative. Distinct gene-set burden patterns underlie common generalized and focal epilepsies. EBioMedicine 2021;72:103588. [PMID: 34571366 DOI: 10.1016/j.ebiom.2021.103588] [Reference Citation Analysis]